Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ECO

Okeanis Eco Tankers Corp

62.70

Aug 17 • 3:59 PM ET +2.41 (4.00%)

62.69

Aftermarket • 7:34 PM ET -0.01 (-0.02%)

Industrials Marine Shipping Greece Mid NYSE

Aug 14, 4:30 AMEx-dividend date for $5.25 payout drives ECO's 6.62% premarket drop

Peers: HAFN INSW FRO STNG TNK DHT CMBT NAT TRMD TK

| Held by: FFTY PXJ DFIS EIPX DFIC BAMD SMCP FTKI DFAI DXIV

Index	-
Market Cap	2.40B
Enterprise Value	2.89B
Income	402.14M
Sales	706.47M
Book/sh	22.47
Cash/sh	6.30
Dividend Est.	14.49 (23.11%)
Dividend TTM	9.55 (15.23%)
Dividend Ex-Date	Aug 14, 2026
Dividend Gr. 3/5Y	52.31% 9.45%
Payout	56.17%
Employees	14
IPO	Mar 30, 2020

P/E	5.85
Forward P/E	9.05
PEG	0.68
P/S	3.40
P/B	2.79
P/C	9.95
P/FCF	53.80
EV/EBITDA	5.94
EV/Sales	4.08
Quick Ratio	4.13
Current Ratio	4.43
Debt/Eq	0.82
LT Debt/Eq	0.76
Option/Short	Yes / Yes

EPS (ttm)	10.72
EPS next Y	6.93
EPS next Q	4.45
EPS this Y	328.54%
EPS next Y	-57.13%
EPS next 5Y	13.29%
EPS past 3/5Y	12.85% 3.87%
Sales past 3/5Y	13.05% 6.72%
EPS Y/Y TTM	413.89%
Sales Y/Y TTM	105.24%
EPS Q/Q	606.35%
Sales Q/Q	239.40%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	28.23% 21.73%

Insider Own	48.77%
Insider Trans	-0.82%
Inst Own	27.09%
Inst Trans	12.00%
ROA	29.44%
ROE	61.59%
ROIC	25.97%
Gross Margin	65.87%
Oper. Margin	62.34%
Profit Margin	56.92%
SMA20	4.39%
SMA50	12.83%
SMA200	33.62%
Trades

Shs Outstand	39.04M
Shs Float	20.00M
Short Float	3.54%
Short Ratio	1.43
Short Interest	0.71M
52W High	65.87 -4.81%
52W Low	25.47 146.17%
Volatility	3.45% 3.57%
ATR (14)	2.67
RSI (14)	58.90
Beta	-0.39
Rel Volume	1.34
Avg Volume	496.77K
Volume	665,123

Perf Week	3.62%
Perf Month	16.37%
Perf Quarter	13.75%
Perf Half Y	45.88%
Perf YTD	85.28%
Perf Year	141.90%
Perf 3Y	148.32%
Perf 5Y	657.25%
Perf 10Y	-
Recom	2.25
Target Price	66.72
Prev Close	60.29
Price	62.70
Change %	4.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-26-26	Downgrade	Pareto	Buy → Hold	$57.50
Jan-27-26	Upgrade	Clarksons Platou	Neutral → Buy	$46.05
Nov-14-25	Downgrade	UBS	Buy → Neutral
Jul-23-25	Initiated	Jefferies	Buy	$29
Apr-16-24	Initiated	B. Riley Securities	Buy	$38

Aug-13-26 12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire)
Aug-05-26 05:03PM	Okeanis Eco Tankers Corp (ECO) (Q2 2026) Earnings Call Highlights: Record Quarter Fueled by ... (GuruFocus.com) +5.21%
Aug-04-26 04:30PM	Okeanis Eco Tankers Corp. - 2025 ESG Report (GlobeNewswire)
04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q2 2026 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. - Unaudited Condensed Financial Statements for the Second Quarter and Six-Month Period of 2026 (GlobeNewswire)
09:38AM	Loading…
09:38AM	Earnings To Watch: Okeanis Eco Tankers Corp (ECO) Q2 2026 -- GF Value Sees 50% Downside (GuruFocus.com)
Aug-03-26 09:24AM	Earnings To Watch: Okeanis Eco Tankers Corp (ECO) Q2 2026 -- GF Value Sees 44% Downside (GuruFocus.com)
Jul-30-26 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q2 2026 Results Webcast (GlobeNewswire)
May-29-26 04:15PM	Okeanis Eco Tankers Corp. - 2026 Annual Meeting of Shareholders held (GlobeNewswire)
May-27-26 12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire)
May-14-26 11:00PM	Okeanis Eco Tankers Corp (ECO) Q1 2026 Earnings Call Highlights: Record Earnings and Strategic ... (GuruFocus.com)
May-13-26 04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q1 2026 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. Reports Financial Results for the First Quarter of 2026 (GlobeNewswire)
May-12-26 09:18AM	Okeanis Eco Tankers Corp (ECO) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
May-08-26 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q1 2026 Results Webcast (GlobeNewswire)
12:00AM	Loading…
May-04-26 12:00AM	Okeanis Eco Tankers Corp. - New Financings Update (GlobeNewswire)
Apr-24-26 04:15PM	Okeanis Eco Tankers Corp. - Announcement of 2026 Annual Meeting of Shareholders (GlobeNewswire) +5.02%
Mar-20-26 04:35PM	Okeanis Eco Tankers Corp. - Announcement of Availability of 2025 Annual Report on Form 20-F (GlobeNewswire)
Mar-02-26 07:51AM	5 Stocks With Recent Price Strength Despite a Volatile February (Zacks)
12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire)
Feb-27-26 09:15AM	Seanergy Maritime Holdings Corp (SHIP) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-24-26 09:40AM	Is Air France-KLM (AFLYY) Stock Outpacing Its Transportation Peers This Year? (Zacks) +5.66%
08:55AM	Okeanis Eco Tankers Corp. (ECO) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Feb-23-26 12:00PM	Okeanis Eco Tankers Corp. (ECO) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:15AM	Okeanis Eco Tankers Corp. (ECO) Hit a 52 Week High, Can the Run Continue? (Zacks)
04:21AM	New Strong Buy Stocks for February 23rd (Zacks)
03:55AM	Best Income Stocks to Buy for February 23rd (Zacks)
Feb-19-26 04:02PM	Okeanis Eco Tankers Corp (ECO) Q4 2025 Earnings Call Highlights: Strong Earnings and Strategic ... (GuruFocus.com) +5.57% +5.17%
Feb-18-26 04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q4 2025 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. Reports Financial Results for the Fourth Quarter and Twelve-Month Period of 2025 (GlobeNewswire)
07:27AM	Loading…
07:27AM	Okeanis Eco Tankers Corp (ECO) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-17-26 07:20AM	Okeanis Eco Tankers Corp (ECO) Q4 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-16-26 12:59AM	A Huge Bet on Supertankers Reverberates Through the Oil Market (Bloomberg)
Feb-12-26 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q4 2025 Results Webcast (GlobeNewswire)
Jan-23-26 02:00AM	Okeanis Eco Tankers Corp. - New Shares Issued and Commencement of Trading (GlobeNewswire)
Jan-21-26 07:02AM	Okeanis Eco Tankers Corp. - Completion and pricing of USD 130 million offering of new common shares (GlobeNewswire)
02:00AM	Okeanis Eco Tankers Corp. - Reminder of trading suspension on Euronext Oslo Bors (GlobeNewswire)
Jan-20-26 04:15PM	Okeanis Eco Tankers Corp. - Commercial Update (GlobeNewswire)
Dec-31-25 09:40AM	Are Transportation Stocks Lagging Okeanis Eco Tankers Corp. (ECO) This Year? (Zacks)
Dec-19-25 04:30PM	Okeanis Eco Tankers Corp. - Financial Calendar (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. - New Financings Update (GlobeNewswire)
Dec-10-25 09:40AM	Is Okeanis Eco Tankers Corp. (ECO) Stock Outpacing Its Transportation Peers This Year? (Zacks)
Dec-09-25 12:20PM	Earnings Estimates Moving Higher for Okeanis Eco Tankers Corp. (ECO): Time to Buy? (Zacks)
12:00PM	What Makes Okeanis Eco Tankers Corp. (ECO) a Strong Momentum Stock: Buy Now? (Zacks)
10:00AM	Best Momentum Stock to Buy for December 9th (Zacks)
06:20AM	Best Income Stocks to Buy for December 9th (Zacks)
Dec-01-25 12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire)
Nov-21-25 02:00AM	Okeanis Eco Tankers Corp. - New Shares Issued and Commencement of Trading (GlobeNewswire)
Nov-19-25 07:15AM	Okeanis Eco Tankers Corp. - Completion and pricing of USD 115 million offering of new common shares (GlobeNewswire) -6.59%
02:00AM	Okeanis Eco Tankers Corp. - Reminder of trading suspension on Euronext Oslo Bors (GlobeNewswire)
Nov-13-25 02:03PM	Okeanis Eco Tankers Corp (ECO) Q3 2025 Earnings Call Highlights: Strong Operational Performance ... (GuruFocus.com) +8.76%
Nov-12-25 05:35PM	Okeanis Eco Tankers Corp. (ECO) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:30PM	Okeanis Eco Tankers Corp. - 2024 ESG Report (GlobeNewswire)
04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q3 2025 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. - Unaudited Condensed Financial Statements for the Third Quarter and Nine-Month Period of 2025 (GlobeNewswire)
07:23AM	Okeanis Eco Tankers Corp (ECO) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-11-25 07:25AM	Okeanis Eco Tankers Corp (ECO) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-10-25 09:15AM	Global Ship Lease (GSL) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Nov-07-25 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q3 2025 Results Webcast (GlobeNewswire)
Nov-04-25 06:00PM	GXO Logistics (GXO) Q3 Earnings and Revenues Beat Estimates (Zacks)
03:37AM	Knot Offshore (KNOP) Soars 9.7%: Is Further Upside Left in the Stock? (Zacks)
Oct-13-25 12:00AM	Okeanis Eco Tankers Corp. - Director Resignations (GlobeNewswire)
Oct-06-25 05:42AM	New Strong Buy Stocks for October 6th (Zacks)
03:57AM	Best Income Stocks to Buy for October 6th (Zacks)
Oct-02-25 09:40AM	Is Central Japan Railway Co. (CJPRY) Outperforming Other Transportation Stocks This Year? (Zacks)
Sep-30-25 06:51AM	Best Income Stocks to Buy for September 30th (Zacks)
Sep-25-25 08:04AM	Best Income Stocks to Buy for September 25th (Zacks)
Sep-10-25 09:40AM	Are Transportation Stocks Lagging Cathay Pacific Airways (CPCAY) This Year? (Zacks)
Aug-21-25 12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire) +5.85%
Aug-18-25 12:20PM	Earnings Estimates Rising for Okeanis Eco Tankers Corp. (ECO): Will It Gain? (Zacks)
Aug-15-25 09:40AM	Are Transportation Stocks Lagging Alstom (ALSMY) This Year? (Zacks)
06:27AM	New Strong Buy Stocks for August 15th (Zacks)
Aug-13-25 03:00PM	Okeanis Eco Tankers Corp (ECO) Q2 2025 Earnings Call Highlights: Strong Fleet Performance Amid ... (GuruFocus.com)
Aug-12-25 05:55PM	Okeanis Eco Tankers Corp. (ECO) Tops Q2 Earnings and Revenue Estimates (Zacks)
04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q2 2025 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. - Unaudited Condensed Financial Statements for the Second Quarter and Six-Month Period of 2025 (GlobeNewswire)
Aug-06-25 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q2 2025 Results Conference Call and Webcast (GlobeNewswire)
Aug-01-25 10:00AM	Okeanis Eco Tankers Corp. (ECO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Jul-25-25 12:10PM	Will Okeanis Eco Tankers Corp. (ECO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-11-25 05:03AM	Scorpio Tankers (STNG) Moves 9.2% Higher: Will This Strength Last? (Zacks)
Jun-17-25 04:15PM	Okeanis Eco Tankers Corp. - New Loan Agreement (GlobeNewswire)
Jun-02-25 12:00AM	Okeanis Eco Tankers Corp. - Ex Dividend Date (GlobeNewswire)
May-30-25 04:15PM	Okeanis Eco Tankers Corp. - 2025 Annual Meeting of Shareholders held (GlobeNewswire)
May-14-25 06:35PM	Okeanis Eco Tankers Corp. (ECO) Tops Q1 Earnings and Revenue Estimates (Zacks)
04:20PM	Okeanis Eco Tankers Corp. - Key Information relating to Q1 2025 dividend (GlobeNewswire)
04:15PM	Okeanis Eco Tankers Corp. Reports Financial Results for the First Quarter of 2025 (GlobeNewswire)
May-09-25 04:15PM	Okeanis Eco Tankers Corp. - Invitation to Q1 2025 Results Conference Call and Webcast (GlobeNewswire)
May-08-25 04:15PM	Okeanis Eco Tankers Corp. - New Financings Update (GlobeNewswire)
07:55AM	Costamare (CMRE) Q1 Earnings and Revenues Surpass Estimates (Zacks)
May-07-25 04:50PM	Okeanis Eco Tankers Corp. - Files Two Registration Statements on Form F-3 (GlobeNewswire)
May-06-25 04:19PM	Insights from Industry Leaders: Capital Links Quarterly Shipping Report Q1 2025 (GlobeNewswire)
May-01-25 08:25AM	Kirby (KEX) Q1 Earnings Surpass Estimates (Zacks)
Apr-25-25 04:20PM	Okeanis Eco Tankers Corp. Announcement of 2025 Annual Meeting of Shareholders (GlobeNewswire)
Apr-18-25 09:40AM	Are Transportation Stocks Lagging Air France-KLM (AFLYY) This Year? (Zacks)
Mar-31-25 04:40PM	Okeanis Eco Tankers Corp. Announcement of Availability of 2024 Annual Report on Form 20-F (GlobeNewswire)
Feb-28-25 12:00AM	Okeanis Eco Tankers Corp. Ex Dividend Date (GlobeNewswire)
Feb-19-25 04:20PM	Okeanis Eco Tankers Corp. Key Information relating to Q4 2024 dividend (GlobeNewswire) -6.77%
04:15PM	Okeanis Eco Tankers Corp. Reports Financial Results for the Fourth Quarter and Twelve-Month Period of 2024 (GlobeNewswire)
Feb-13-25 04:10PM	Okeanis Eco Tankers Corp. - Invitation to Q4 2024 Results Conference Call and Webcast (GlobeNewswire)
Jan-16-25 07:40AM	Okeanis Eco price target lowered to $40 from $44 at B. Riley (TipRanks) -5.54%

Okeanis Eco Tankers Corp. is a holding company, which engages in the ownership and operation of commercial shipping vessels. Its activities include the transportation of crude oil, refined oil products, and other liquid products. The firm's portfolio includes Very Large Crude Carriers, Suezmax, and Aframax. The company was founded on April 30, 2018 and is headquartered in Piraeus, Greece.

Chief Executive OfficerMr. Aristidis Alafouzos

Chief Financial OfficerMr. Iraklis Sbarounis

Chief Operating OfficerMr. Michalis Moraitakis

Chief Accounting OfficerMr. Alexandros Giannoulas

Chief Commercial OfficerMr. Christopher Papaioannou

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
QVT Financial LP	Director by Deputization	Aug 14 '26	Sale	59.99	68,420	4,104,516	1,347,038	Aug 17 06:12 PM
QVT Financial LP	Director by Deputization	Aug 13 '26	Sale	65.04	8,539	555,377	1,415,458	Aug 17 06:12 PM
Gold Daniel Allen	Director	Aug 14 '26	Sale	59.99	68,420	4,104,516	1,347,038	Aug 17 06:01 PM
Gold Daniel Allen	Director	Aug 13 '26	Sale	65.04	8,539	555,377	1,415,458	Aug 17 06:01 PM

Open in Screener

ROIV

Roivant Sciences Ltd

36.24

Aug 17 • 3:59 PM ET +0.04 (0.11%)

36.24

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Biotechnology United Kingdom Large NASD

ROIV Roivant Sciences Ltd daily Stock Chart

Peers: INCY MRNA ALNY REGN ARGX VRTX BMRN BIIB AMGN GILD

| Held by: VTI IJH VB VBK XMMO VXF IBB XBI MDY SPMD

Index	-
Market Cap	26.18B
Enterprise Value	23.13B
Income	-266.25M
Sales	7.53M
Book/sh	5.86
Cash/sh	5.32
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	721
IPO	Dec 08, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	3476.36
P/B	6.19
P/C	6.81
P/FCF	-
EV/EBITDA	-
EV/Sales	3071.51
Quick Ratio	16.72
Current Ratio	16.72
Debt/Eq	0.03
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-0.44
EPS next Y	-1.27
EPS next Q	-0.36
EPS this Y	-149.13%
EPS next Y	5.84%
EPS next 5Y	10.62%
EPS past 3/5Y	32.67% 34.68%
Sales past 3/5Y	-48.73% -19.07%
EPS Y/Y TTM	45.61%
Sales Y/Y TTM	-67.58%
EPS Q/Q	19.77%
Sales Q/Q	-33.55%
Earnings	Aug 06 BMO
EPS/Sales Surpr.	-11.72% -29.89%

Insider Own	27.88%
Insider Trans	-4.33%
Inst Own	76.27%
Inst Trans	4.17%
ROA	-5.15%
ROE	-6.21%
ROIC	-6.15%
Gross Margin	43.37%
Oper. Margin	-18146.12%
Profit Margin	-3534.96%
SMA20	3.58%
SMA50	7.20%
SMA200	32.27%
Trades

Shs Outstand	722.67M
Shs Float	520.93M
Short Float	6.76%
Short Ratio	5.84
Short Interest	35.23M
52W High	37.00 -2.05%
52W Low	11.54 214.04%
Volatility	3.04% 3.46%
ATR (14)	1.24
RSI (14)	59.52
Beta	1.13
Rel Volume	1.28
Avg Volume	6.03M
Volume	7,720,293

Perf Week	1.29%
Perf Month	5.01%
Perf Quarter	23.73%
Perf Half Y	37.01%
Perf YTD	67.00%
Perf Year	205.82%
Perf 3Y	246.13%
Perf 5Y	264.59%
Perf 10Y	-
Recom	1.31
Target Price	41.82
Prev Close	36.20
Price	36.24
Change %	0.11%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-20-26	Initiated	Bernstein	Outperform	$35
Sep-02-25	Initiated	Citigroup	Buy	$16
Jul-10-25	Resumed	Goldman	Buy	$19
Feb-15-24	Initiated	Wolfe Research	Outperform	$17
Jan-05-24	Initiated	Piper Sandler	Overweight	$20
Dec-12-23	Initiated	Deutsche Bank	Buy	$14
Oct-17-23	Initiated	Guggenheim	Buy	$17
Jun-08-23	Initiated	BofA Securities	Neutral	$10.50
Oct-27-22	Initiated	JP Morgan	Overweight	$7
May-23-22	Initiated	SVB Leerink	Outperform	$6
Apr-29-22	Initiated	Cantor Fitzgerald	Overweight	$15
Dec-15-21	Initiated	Goldman	Buy	$15
Nov-08-21	Initiated	H.C. Wainwright	Buy	$14
Oct-28-21	Initiated	Citigroup	Buy	$11
Oct-26-21	Initiated	Truist	Buy	$15
Oct-26-21	Initiated	Jefferies	Buy	$10
Oct-26-21	Initiated	Cowen	Outperform

Show Previous Ratings

Aug-07-26 08:30AM	Roivant Sciences Ltd. Q1 2026 Earnings Call Summary (Moby)
Aug-06-26 03:02PM	Roivant Sciences Ltd (ROIV) (Q1 2026) Earnings Call Highlights: Strategic Advances and Strong ... (GuruFocus.com)
07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update (GlobeNewswire)
07:00AM	Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) (GlobeNewswire)
Jul-23-26 04:05PM	Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 (GlobeNewswire)
02:28PM	Loading…
Jul-07-26 02:28PM	ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week (Stocktwits)
May-20-26 03:00PM	Roivant Sciences Ltd (ROIV) Q4 2025 Earnings Call Highlights: Strategic Settlements and ... (GuruFocus.com) +14.89%
01:20PM	Can a New Arthritis Drug Make Immunovant the Next Biotech Star? (Barrons.com)
11:38AM	2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug (Barrons.com)
08:45AM	Roivant Shares Climb on Earnings Beat Despite Revenue Shortfall (ROIV) (InvestorsHub)
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update (GlobeNewswire)
May-11-26 04:05PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026 (GlobeNewswire)
Apr-02-26 05:00AM	Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) (GlobeNewswire)
05:00AM	Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) (GlobeNewswire)
Mar-28-26 03:00PM	New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis (GlobeNewswire)
04:04PM	Loading…
Mar-04-26 04:04PM	Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily) +6.00%
02:35PM	Moderna Settles a Covid Vaccine Patent Lawsuit. What It Means for the Stock. (Barrons.com)
09:55AM	MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS (Zacks)
09:15AM	Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna (The Wall Street Journal)
09:01AM	Moderna Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily)
08:40AM	Moderna and Ross Stores Lead Stock Gainers on Wednesday (24/7 Wall St.)
08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
Mar-03-26 04:15PM	Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna (GlobeNewswire)
07:00AM	Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis (GlobeNewswire)
Feb-14-26 01:29AM	Citi Raises Roivant Sciences (ROIV) PT to $35 Following Positive Phase 2 Brepocitinib Data (Insider Monkey)
Feb-10-26 06:41AM	TD Cowen Remains Bullish on Roivant Sciences Ltd. (ROIV) - Here's Why (Insider Monkey)
Feb-08-26 08:39AM	Lumentum, Woodward, And Teradyne Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
Feb-07-26 06:38AM	Roivant Sciences (ROIV) Soars 19.4% as Pipeline Drugs Progress (Insider Monkey)
Feb-06-26 02:05PM	Roivant Stock Soars On Experimental Skin Drug Delivering 100% Response - Why It Matters (Benzinga) +22.14%
02:00PM	Roivant Sciences Ltd (ROIV) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ... (GuruFocus.com)
01:25PM	Loading…
01:25PM	Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? (Benzinga)
10:10AM	Roivant Sciences Q3 Earnings Call Highlights (MarketBeat)
10:03AM	Roivant Sciences Catapults On A 'Dream Scenario' For Its Blockbuster Hopeful (Investor's Business Daily)
08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025 (GlobeNewswire)
07:00AM	Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) (GlobeNewswire)
Feb-01-26 07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-23-26 04:15PM	Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 (GlobeNewswire)
Jan-20-26 10:31AM	Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report (Benzinga)
Jan-02-26 10:50AM	Leerink Raises Price Target as Roivant (ROIV) Accelerates Drug Development Pipeline (Insider Monkey)
Dec-22-25 08:10AM	Insider Action: Multimillion-dollar sell-offs across major U.S. companies (CNBC TV)
Dec-11-25 07:30AM	Roivant Highlights Continued Pipeline Progress and Outlook for Company's Next Phase of Growth at 2025 Investor Day (GlobeNewswire) +5.43%
Dec-10-25 02:00AM	A Roivant spinout bets on AI-designed drugs for immune conditions (BioPharma Dive)
02:00AM	A former Roivant spinout bets on AI-designed drugs for immune conditions (BioPharma Dive)
Nov-10-25 02:01PM	Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Call Highlights: Strong Financial Position and ... (GuruFocus.com)
08:25AM	Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update (GlobeNewswire)
Nov-06-25 09:15AM	Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-05-25 09:10AM	LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 07:30AM	Do You Believe in the Growth Prospects of Roivant Sciences Ltd. (ROIV)? (Insider Monkey)
Oct-27-25 04:10PM	Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025 (GlobeNewswire)
Oct-21-25 05:52AM	Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV) (Insider Monkey)
Oct-04-25 04:54PM	Roivant's Brepocitinib Phase 3 Dermatomyositis Trial Hits Primary and All Key Secondary Endpoints (Insider Monkey)
Sep-29-25 08:01PM	Vivek Ramaswamy's Bitcoin Play Just Got Bigger: This $1.3B Deal Could Signal Corporate Crypto's Next Phase (Benzinga)
Sep-23-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Roivant Sciences Ltd. (ROIV) is a Great Choice (Zacks)
Sep-22-25 10:21AM	Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings (Reuters)
Sep-18-25 10:47AM	Roivant Sciences (ROIV) Hits New All-Time High as Drug Candidate Clinical Trial Posts Impressive Results (Insider Monkey)
10:34AM	Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains? (Zacks)
Sep-17-25 04:11PM	Roivant Flirts With A Profit-Taking Zone, Stoked By Promise In Autoimmune Disease (Investor's Business Daily) +7.76%
12:49PM	Why Roivant Sciences Stock Is Soaring Today (Motley Fool)
07:00AM	Roivant and Priovant Announce Positive Phase 3 VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM) (GlobeNewswire)
Sep-14-25 04:00AM	Vivek Ramaswamy Sells $22.7 Million of Roivant Sciences Stock (Barrons.com)
Sep-11-25 04:30PM	Roivant Named on Fortune Media and Great Place To Work's 2025 Best Workplaces in BioPharma List (GlobeNewswire)
11:11AM	Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat (Insider Monkey)
Sep-03-25 01:01PM	Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients (GlobeNewswire)
Aug-28-25 11:49PM	Roivant Sciences (ROIV) Announces Q1 2025 Business Update (Insider Monkey)
Aug-12-25 06:42PM	Why Roivant Sciences Stock Bounced Back on Tuesday (Motley Fool)
03:02AM	Roivant Sciences Ltd (ROIV) Q1 2025 Earnings Call Highlights: Strong Cash Position and ... (GuruFocus.com)
Aug-11-25 04:58PM	Why Roivant Sciences Stock Was Slipping on Monday (Motley Fool)
08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update (GlobeNewswire)
Aug-08-25 09:17AM	What To Expect From Roivant Sciences Ltd (ROIV) Q1 2026 Earnings (GuruFocus.com)
Aug-07-25 06:15PM	Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-05-25 08:10AM	Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-28-25 04:05PM	Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025 (GlobeNewswire)
Jul-24-25 11:47PM	Goldman Sachs Resumes Roivant Sciences (ROIV) Coverage with 'Buy' Rating (Insider Monkey)
Jul-11-25 06:20AM	Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar? (Zacks)
Jun-24-25 12:45PM	Roivant Sciences Subsidiary Pulmovant Publishes Positive Phase 1 Data for Inhaled PH Treatment Mosliciguat (Insider Monkey)
Jun-16-25 07:00AM	Pulmovant Announces Publication of Pharmacokinetics and Lung Deposition Data for Inhaled Mosliciguat in Clinical Pharmacokinetics (GlobeNewswire)
Jun-09-25 04:05PM	Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis (GlobeNewswire)
May-29-25 08:15AM	Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +6.40%
07:00AM	Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update (GlobeNewswire)
May-28-25 02:17PM	H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock (Insider Monkey)
09:15AM	What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings (GuruFocus.com)
May-15-25 05:15PM	Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025 (GlobeNewswire)
May-14-25 05:40PM	Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-13-25 05:10PM	Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-08-25 07:45AM	Liquidia Technologies, Inc. (LQDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-06-25 06:20AM	Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar? (Zacks)
May-02-25 10:37AM	Roivant Sciences Ltd. (ROIV): Among David Einhorn's Stock Picks with Huge Upside Potential (Insider Monkey)
Apr-29-25 11:35AM	Roivant Sciences Ltd. (ROIV): Among Billionaire Andreas Halvorsen's Stock Picks With Huge Upside Potential (Insider Monkey)
Apr-23-25 12:13PM	Roivant Sciences: Primed For Growth With A De-Risked Pipeline (Seeking Alpha)
Apr-21-25 04:08PM	Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug (Investor's Business Daily)
10:18AM	Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift (Investor's Business Daily)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjogren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
07:00AM	Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sj gren's Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402 (GlobeNewswire)
Apr-14-25 06:20AM	Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now? (Zacks)
Apr-11-25 03:07PM	Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? (Insider Monkey)
10:04AM	Certara (CERT) Soars 8.0%: Is Further Upside Left in the Stock? (Zacks)

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

CEO & DirectorMr. Matthew Gline

Pharm.D.Dr. Eric Venker M.D.

PresidentDr. Mayukh Sukhatme M.D.

M.D.Dr. Frank M. Torti M.B.A.

Chief Financial OfficerMr. Richard Pulik

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MAYUKH SUKHATME	Officer	Aug 17 '26	Proposed Sale	36.25	284,707	10,320,572		Aug 17 04:40 PM
MAYUKH SUKHATME	Officer	Aug 14 '26	Proposed Sale	36.23	243,177	8,809,768		Aug 14 04:20 PM
Venker Eric	President & Immunovant CEO	Jul 27 '26	Option Exercise	3.85	200,000	770,000	1,813,063	Jul 29 09:00 PM
Venker Eric	President & Immunovant CEO	Jul 27 '26	Sale	34.95	200,000	6,990,000	1,613,063	Jul 29 09:00 PM
Venker Eric	Officer	Jul 27 '26	Proposed Sale	34.95	200,000	6,989,924		Jul 27 04:16 PM
Fitzgerald Meghan	Director	Jun 30 '26	Option Exercise	8.80	10,000	88,000	52,963	Jul 02 07:03 PM
Fitzgerald Meghan	Director	Jun 30 '26	Sale	34.90	10,000	349,000	42,963	Jul 02 07:03 PM
Epperly Melissa B,	Director	Jun 29 '26	Option Exercise	4.46	17,750	79,165	34,224	Jul 01 06:34 PM
Epperly Melissa B,	Director	Jun 29 '26	Sale	34.38	17,750	610,252	16,474	Jul 01 06:34 PM
MANCHESTER KEITH S	Director	Jun 29 '26	Sale	34.55	800,000	27,642,000	13,701,546	Jun 30 08:38 PM
MANCHESTER KEITH S	Director	Jun 26 '26	Sale	34.00	625,783	21,275,309	14,501,546	Jun 30 08:38 PM
MANCHESTER KEITH S	Director	Jun 30 '26	Sale	35.45	200,000	7,090,000	1,748,403	Jun 30 08:38 PM
MANCHESTER KEITH S	Director	Jun 30 '26	Sale	35.28	12,380	436,766	13,689,166	Jun 30 08:38 PM
Gold Daniel Allen	Director	Jun 29 '26	Sale	34.55	800,000	27,642,000	13,701,546	Jun 30 08:30 PM
Gold Daniel Allen	Director	Jun 26 '26	Sale	34.00	625,783	21,275,309	14,501,546	Jun 30 08:30 PM
Gold Daniel Allen	Director	Jun 30 '26	Sale	35.28	12,380	436,766	13,689,166	Jun 30 08:30 PM
QVT Financial LP	Director by Deputization	Jun 29 '26	Sale	34.55	800,000	27,642,000	13,701,546	Jun 30 07:59 PM
QVT Financial LP	Director by Deputization	Jun 26 '26	Sale	34.00	625,783	21,275,309	14,501,546	Jun 30 07:59 PM
QVT Financial LP	Director by Deputization	Jun 30 '26	Sale	35.28	12,380	436,766	13,689,166	Jun 30 07:59 PM
MEGHAN FITZGERALD	Director	Jun 30 '26	Proposed Sale	34.73	10,000	347,300		Jun 30 04:36 PM
KEITH S MANCHESTER	Director	Jun 30 '26	Proposed Sale	35.45	200,000	7,090,280		Jun 30 04:25 PM
MELISSA EPPERLY	Director	Jun 29 '26	Proposed Sale	34.07	17,750	604,742		Jun 29 04:40 PM
Venker Eric	President & Immunovant CEO	Jun 24 '26	Option Exercise	3.85	200,000	770,000	1,813,063	Jun 26 06:13 PM
Venker Eric	President & Immunovant CEO	Jun 24 '26	Sale	33.16	200,000	6,631,268	1,613,063	Jun 26 06:13 PM
MAYUKH SUKHATME	Officer	Jun 26 '26	Proposed Sale	34.08	500,000	17,039,650		Jun 26 04:10 PM
MAYUKH SUKHATME	Officer	Jun 25 '26	Proposed Sale	34.13	500,000	17,066,500		Jun 25 04:33 PM
Venker Eric	Officer	Jun 24 '26	Proposed Sale	33.16	200,000	6,631,659		Jun 24 04:01 PM
Venker Eric	President & Immunovant CEO	May 22 '26	Option Exercise	3.85	200,000	770,000	1,813,063	May 22 06:25 PM
Venker Eric	President & Immunovant CEO	May 22 '26	Sale	30.27	200,000	6,054,000	1,613,063	May 22 06:25 PM
Venker Eric	Officer	May 22 '26	Proposed Sale	30.27	200,000	6,054,731		May 22 04:00 PM
Venker Eric	President & Immunovant CEO	Apr 20 '26	Option Exercise	3.85	200,000	770,000	1,847,546	Apr 22 06:27 PM
Venker Eric	President & Immunovant CEO	Apr 20 '26	Sale	29.59	200,000	5,918,000	1,647,546	Apr 22 06:27 PM
Gline Matthew	CEO	Apr 16 '26	Sale	29.16	289,774	8,449,810	16,736,116	Apr 20 06:27 PM
Venker Eric	Officer	Apr 20 '26	Proposed Sale	29.59	200,000	5,917,135		Apr 20 04:17 PM
Gline Matthew	Officer	Apr 16 '26	Proposed Sale	29.16	289,774	8,449,876		Apr 16 04:33 PM
Humes Jennifer	Chief Accounting Officer	Apr 08 '26	Sale	28.37	13,538	384,073	84,191	Apr 10 06:00 PM
JENNIFER HUMES	Officer	Apr 08 '26	Proposed Sale	28.37	13,538	384,035		Apr 08 04:07 PM
Fitzgerald Meghan	Director	Mar 26 '26	Option Exercise	8.80	70,000	616,000	112,963	Mar 30 09:01 PM
Fitzgerald Meghan	Director	Mar 26 '26	Sale	27.45	70,000	1,921,500	42,963	Mar 30 09:01 PM
MEGHAN FITZGERALD	Director	Mar 26 '26	Proposed Sale	27.45	70,000	1,921,458		Mar 26 04:14 PM
Venker Eric	President & Immunovant CEO	Mar 17 '26	Option Exercise	3.85	200,000	770,000	1,847,546	Mar 19 06:36 PM
Venker Eric	President & Immunovant CEO	Mar 17 '26	Sale	28.24	200,000	5,648,000	1,647,546	Mar 19 06:36 PM
Epperly Melissa B,	Director	Mar 16 '26	Sale	28.68	41,861	1,200,573	15,804	Mar 18 06:23 PM
Venker Eric	Officer	Mar 17 '26	Proposed Sale	28.24	200,000	5,648,836		Mar 17 04:17 PM
MELISSA B EPPERLY	Director	Mar 16 '26	Proposed Sale	28.68	41,861	1,200,498		Mar 16 04:04 PM
Torti Frank	President and Vant Chair	Feb 19 '26	Option Exercise	3.85	1,400,000	5,390,000	15,136,547	Feb 23 08:40 PM
Torti Frank	President and Vant Chair	Feb 20 '26	Option Exercise	3.85	1,012,610	3,898,548	14,749,157	Feb 23 08:40 PM
Torti Frank	President and Vant Chair	Feb 23 '26	Option Exercise	3.85	587,390	2,261,452	14,323,937	Feb 23 08:40 PM
Torti Frank	President and Vant Chair	Feb 19 '26	Sale	27.42	1,400,000	38,388,000	13,736,547	Feb 23 08:40 PM
Torti Frank	President and Vant Chair	Feb 20 '26	Sale	27.15	1,012,610	27,492,362	13,736,547	Feb 23 08:40 PM
Torti Frank	President and Vant Chair	Feb 23 '26	Sale	27.51	587,390	16,159,099	13,736,547	Feb 23 08:40 PM
FRANK TORTI	Officer	Feb 20 '26	Proposed Sale	27.52	1,600,000	44,032,000		Feb 20 04:29 PM
FRANK TORTI	Officer	Feb 19 '26	Proposed Sale	27.48	1,400,000	38,472,000		Feb 19 04:24 PM
Venker Eric	President & Immunovant CEO	Feb 13 '26	Option Exercise	3.85	200,000	770,000	1,854,597	Feb 18 05:57 PM
Venker Eric	President & Immunovant CEO	Feb 13 '26	Sale	26.49	200,000	5,298,000	1,654,597	Feb 18 05:57 PM
MANCHESTER KEITH S	Director	Feb 12 '26	Sale	26.75	425,000	11,367,000	15,503,113	Feb 13 09:02 PM
MANCHESTER KEITH S	Director	Feb 11 '26	Sale	26.67	425,000	11,334,750	15,928,113	Feb 13 09:02 PM
MANCHESTER KEITH S	Director	Feb 13 '26	Sale	26.50	375,784	9,956,768	15,127,329	Feb 13 09:02 PM
Gold Daniel Allen	Director	Feb 12 '26	Sale	26.75	425,000	11,367,000	15,503,113	Feb 13 09:00 PM
Gold Daniel Allen	Director	Feb 11 '26	Sale	26.67	425,000	11,334,750	15,928,113	Feb 13 09:00 PM
Gold Daniel Allen	Director	Feb 13 '26	Sale	26.50	375,784	9,956,768	15,127,329	Feb 13 09:00 PM
QVT Financial LP	Director by Deputization	Feb 12 '26	Sale	26.75	425,000	11,367,000	15,503,113	Feb 13 08:45 PM
QVT Financial LP	Director by Deputization	Feb 11 '26	Sale	26.67	425,000	11,334,750	15,928,113	Feb 13 08:45 PM
QVT Financial LP	Director by Deputization	Feb 13 '26	Sale	26.50	375,784	9,956,768	15,127,329	Feb 13 08:45 PM
Venker Eric	Officer	Feb 13 '26	Proposed Sale	26.49	200,000	5,298,373		Feb 13 04:21 PM
Sukhatme Mayukh	President & CIO	Feb 09 '26	Option Exercise	12.68	651,558	8,261,755	19,488,105	Feb 11 05:53 PM
Sukhatme Mayukh	President & CIO	Feb 09 '26	Sale	26.47	339,441	8,985,003	19,148,664	Feb 11 05:53 PM
Sukhatme Mayukh	Officer	Feb 09 '26	Proposed Sale	26.47	339,441	8,985,276		Feb 09 04:13 PM
Venker Eric	President & Immunovant CEO	Jan 12 '26	Option Exercise	3.85	200,000	770,000	1,854,597	Jan 14 09:00 PM
Venker Eric	President & Immunovant CEO	Jan 12 '26	Sale	21.92	200,000	4,384,000	1,654,597	Jan 14 09:00 PM
Venker Eric	Officer	Jan 12 '26	Proposed Sale	21.92	200,000	4,383,694		Jan 12 04:04 PM
Sukhatme Mayukh	President & CIO	Dec 31 '25	Option Exercise	12.68	2,449,877	31,064,440	21,286,424	Dec 31 09:00 PM
Sukhatme Mayukh	President & CIO	Dec 29 '25	Option Exercise	12.68	748,358	9,489,179	19,584,905	Dec 31 09:00 PM
Sukhatme Mayukh	President & CIO	Dec 31 '25	Sale	21.71	1,018,995	22,122,381	20,267,429	Dec 31 09:00 PM
Sukhatme Mayukh	President & CIO	Dec 29 '25	Sale	21.74	311,873	6,780,119	19,273,032	Dec 31 09:00 PM
Sukhatme Mayukh	Officer	Dec 31 '25	Proposed Sale	21.71	1,018,995	22,119,828		Dec 31 04:30 PM
Pulik Richard	CFO	Dec 23 '25	Option Exercise	3.85	260,000	1,001,000	646,144	Dec 29 09:00 PM
Pulik Richard	CFO	Dec 23 '25	Sale	22.43	406,731	9,122,307	239,413	Dec 29 09:00 PM
Venker Eric	President & Immunovant CEO	Dec 23 '25	Option Exercise	3.85	313,841	1,208,288	1,811,749	Dec 29 09:00 PM
Venker Eric	President & Immunovant CEO	Dec 24 '25	Option Exercise	3.85	117,848	453,715	1,729,597	Dec 29 09:00 PM
Venker Eric	President & Immunovant CEO	Dec 23 '25	Sale	22.45	200,000	4,490,000	1,611,749	Dec 29 09:00 PM
Venker Eric	President & Immunovant CEO	Dec 24 '25	Sale	22.53	75,000	1,689,750	1,654,597	Dec 29 09:00 PM
Sukhatme Mayukh	Officer	Dec 29 '25	Proposed Sale	21.74	311,873	6,781,263		Dec 29 04:31 PM
ERIC VENKER	Officer	Dec 24 '25	Proposed Sale	22.53	75,000	1,689,562		Dec 29 09:36 AM
FRANK M TORTI	Officer	Dec 24 '25	Proposed Sale	22.47	64,891	1,458,373		Dec 29 09:05 AM
RICHARD PULIK	Officer	Dec 23 '25	Proposed Sale	22.45	260,000	5,835,726		Dec 23 04:19 PM
RICHARD PULIK TRUST	Officer	Dec 23 '25	Proposed Sale	22.39	146,731	3,285,755		Dec 23 04:07 PM
ERIC VENKER	Officer	Dec 23 '25	Proposed Sale	22.45	200,000	4,490,540		Dec 23 04:04 PM
Sukhatme Mayukh	President & CIO	Dec 17 '25	Option Exercise	12.68	59,513	754,625	18,896,060	Dec 19 09:04 PM
Sukhatme Mayukh	President & CIO	Dec 17 '25	Sale	23.09	26,831	619,528	18,869,229	Dec 19 09:04 PM
Gold Daniel Allen	Director	Dec 16 '25	Sale	23.04	917,282	21,129,619	17,130,445	Dec 18 07:54 PM
Gold Daniel Allen	Director	Dec 17 '25	Sale	23.07	777,332	17,935,595	16,353,113	Dec 18 07:54 PM
MANCHESTER KEITH S	Director	Dec 16 '25	Sale	23.04	917,282	21,129,619	17,130,445	Dec 18 07:52 PM
MANCHESTER KEITH S	Director	Dec 17 '25	Sale	23.07	777,332	17,935,595	16,353,113	Dec 18 07:52 PM
QVT Financial LP	Director by Deputization	Dec 16 '25	Sale	23.04	917,282	21,129,619	17,130,445	Dec 18 07:41 PM
QVT Financial LP	Director by Deputization	Dec 17 '25	Sale	23.07	777,332	17,935,595	16,353,113	Dec 18 07:41 PM
Gline Matthew	CEO	Dec 15 '25	Option Exercise	12.16	3,870,659	47,062,049	19,559,933	Dec 17 09:00 PM
Gline Matthew	CEO	Dec 15 '25	Sale	21.68	1,740,000	37,723,200	17,290,820	Dec 17 09:00 PM
Sukhatme Mayukh	Officer	Dec 17 '25	Proposed Sale	23.09	26,831	619,488		Dec 17 05:09 PM
Ramaswamy Vivek	10% Owner	Dec 12 '25	Option Exercise	12.68	4,672,724	59,250,140	38,326,479	Dec 15 09:34 PM

ECO

Okeanis Eco Tankers Corp

ROIV

Roivant Sciences Ltd

Upgrade your Finviz experience